Opportunities and options for treatment research in resource-constrained settings

Clinical Infectious Diseases

Volumn 37, Issue SUPPL. 1, 2003, Pages

  Volberding, Paul A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

CLINICAL TRIAL; COHORT ANALYSIS; DIARRHEA; DRUG SURVEILLANCE PROGRAM; EVIDENCE BASED MEDICINE; FINANCIAL MANAGEMENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MEDICAL DECISION MAKING; METABOLIC DISORDER; PRIORITY JOURNAL; SALVAGE THERAPY; SHORT SURVEY; SIDE EFFECT; T LYMPHOCYTE;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CLINICAL TRIALS; COHORT STUDIES; DRUG THERAPY, COMBINATION; HEALTH RESOURCES; HIV INFECTIONS; HUMANS; PROSPECTIVE STUDIES; RESEARCH DESIGN;

EID: 0038573487     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/375366     Document Type: Short Survey

References (0)